The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Dr. Ritu Salani shared her advice for patients undergoing advanced treatment options for their cervical cancer who are ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Dr. Anna Arthur discusses how the NOURISH trial is addressing food insecurity and malnutrition in patients undergoing ...

Palliative care consultations helped patients with esophageal cancer at end-of-life experience better quality of life and ...

Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...

Despite the initial shock and challenges, I found strength and support within the community of single parents.

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...